Assessment of trial design recommendations for pivotal psychiatric drug trials (Protocol) Kim Boesen, 1 Peter C Gøtzsche, 2 John PA Ioannidis 3, 4 1 Nordic Cochrane Centre, Rigshospitalet, Dept. 7811, Copenhagen, Denmark 2 Institute for Scientific Freedom, Denmark 3 Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA 4 Departments of Medicine, of Health Research and Policy, Biomedical Data Science, and Statistics, Stanford University, Stanford, CA, USA Corresponding author Kim Boesen Nordic Cochrane Centre Rigshospitalet, Dept. 7811 Blegdamsvej 9 2100 Copenhagen Ø +45 35457112 kb@cochrane.dk Word count: 1852
